| 利妥昔单抗维持治疗可提高滤泡淋巴瘤无进展生存率 |
| |
| 引用本文： | 李文瑜,陈菲莉. 利妥昔单抗维持治疗可提高滤泡淋巴瘤无进展生存率[J]. 循证医学, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005 |
| |
| 作者姓名： | 李文瑜 陈菲莉 |
| |
| 作者单位： | 广东省人民医院惠福分院肿瘤中心淋巴瘤科、广东省医学科学院, 广州510080 |
| |
| 摘 要： |
|
| 关 键 词： | 利妥昔单抗 滤泡淋巴瘤 |
Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance |
| |
| Reviewer：LI Wen-yu,CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. The Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005 |
| |
| Authors: | Reviewer：LI Wen-yu CHEN Fei-li |
| |
| Affiliation: | Authors'address： Lymphoma Department, Cancer Center, Huifu Branch of Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences, Guangzhou 510080, China |
| |
| Abstract: | |
| |
| Keywords: | Rituximab follicular lymphoma |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
|
点击此处可从《循证医学》下载免费的PDF全文 |
|
